BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28732488)

  • 1. Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer.
    Quadri HS; Aiken TJ; Allgaeuer M; Moravec R; Altekruse S; Hussain SP; Miettinen MM; Hewitt SM; Rudloff U
    BMC Cancer; 2017 Jul; 17(1):495. PubMed ID: 28732488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling.
    Li D; Miermont AM; Sable R; Quadri HS; Mathews Griner LA; Martin SE; Odzorig T; De S; Ferrer M; Powers AS; Hewitt SM; Rudloff U
    Mol Cancer Res; 2023 Apr; 21(4):316-331. PubMed ID: 36790955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker.
    Hiraoka K; Hida Y; Miyamoto M; Oshikiri T; Suzuoki M; Nakakubo Y; Shinohara T; Itoh T; Shichinohe T; Kondo S; Kasahara N; Katoh H
    Int J Cancer; 2002 May; 99(3):418-23. PubMed ID: 11992411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNKSR1 gene defect can cause syndromic autosomal recessive intellectual disability.
    Kazeminasab S; Taskiran II; Fattahi Z; Bazazzadegan N; Hosseini M; Rahimi M; Oladnabi M; Haddadi M; Celik A; Ropers HH; Najmabadi H; Kahrizi K
    Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):691-699. PubMed ID: 30450701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adenocarcinoma.
    Chang DT; Chapman CH; Norton JA; Visser B; Fisher GA; Kunz P; Ford JM; Koong AC; Pai RK
    Cancer; 2010 Nov; 116(22):5179-87. PubMed ID: 20665497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP.
    Nishiyama K; Maekawa M; Nakagita T; Nakayama J; Kiyoi T; Chosei M; Murakami A; Kamei Y; Takeda H; Takada Y; Higashiyama S
    Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34187934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
    Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma.
    Nishio K; Kimura K; Amano R; Nakata B; Yamazoe S; Ohira G; Miura K; Kametani N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
    World J Gastroenterol; 2017 Aug; 23(31):5764-5772. PubMed ID: 28883702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis.
    Mizumoto Y; Kyo S; Mori N; Sakaguchi J; Ohno S; Maida Y; Hashimoto M; Takakura M; Inoue M
    Cancer Sci; 2007 May; 98(5):652-8. PubMed ID: 17388789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
    Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
    BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of pS2 protein and heat shock protein-70 in pancreatic adenocarcinomas. Relationship with disease extent and patient survival.
    Sagol O; Tuna B; Coker A; Karademir S; Obuz F; Astarcioglu H; Küpelioglu A; Astarcioglu I; Topalak O
    Pathol Res Pract; 2002; 198(2):77-84. PubMed ID: 11928868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis.
    Weichert W; Boehm M; Gekeler V; Bahra M; Langrehr J; Neuhaus P; Denkert C; Imre G; Weller C; Hofmann HP; Niesporek S; Jacob J; Dietel M; Scheidereit C; Kristiansen G
    Br J Cancer; 2007 Aug; 97(4):523-30. PubMed ID: 17622249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo.
    Angst E; Dawson DW; Stroka D; Gloor B; Park J; Candinas D; Reber HA; Hines OJ; Eibl G
    Surgery; 2011 May; 149(5):614-24. PubMed ID: 21236457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer.
    Ahrendt SA; Brown HM; Komorowski RA; Zhu YR; Wilson SD; Erickson BA; Ritch PS; Pitt HA; Demeure MJ
    Surgery; 2000 Oct; 128(4):520-30. PubMed ID: 11015084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer.
    Javle MM; Gibbs JF; Iwata KK; Pak Y; Rutledge P; Yu J; Black JD; Tan D; Khoury T
    Ann Surg Oncol; 2007 Dec; 14(12):3527-33. PubMed ID: 17879119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of SMAD4 as a diagnostic immunohistochemical marker for pancreatic adenocarcinoma, and its expression in other solid tumors.
    Ali S; Cohen C; Little JV; Sequeira JH; Mosunjac MB; Siddiqui MT
    Diagn Cytopathol; 2007 Oct; 35(10):644-8. PubMed ID: 17854080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of p27Kip1 expression independently predicts poor prognosis for patients with resectable pancreatic adenocarcinoma.
    Lu CD; Morita S; Ishibashi T; Hara H; Isozaki H; Tanigawa N
    Cancer; 1999 Mar; 85(6):1250-60. PubMed ID: 10189129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.